NL-OMON46890已完成不适用
Establishing a Single-sex Controlled Human Schistosoma mansoni Infection Model: safety and dose finding - Controlled Human Schistosoma mansoni Infection (CoHSI1)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Subject is aged * 18 and * 45 years and in good health.
- •2. Subject has adequate understanding of the procedures of the study and agrees to abide strictly thereby.
- •3. Subject is able to communicate well with the investigator, is available to attend all study visits.
- •4. Subject will remain within Europe (excluding Corsica) during the study period and is reachable by mobile telephone from week 3 to week 12 of the study period.
- •5. Subject agrees to refrain from blood donation to Sanquin or for other purposes throughout the study period.
- •6. For female subjects: subject agrees to use adequate contraception and not to breastfeed for the duration of study.
- •7. Subject has signed informed consent.
排除标准
- •1. Any history, or evidence at screening, of clinically significant symptoms, physical signs or abnormal laboratory values suggestive of systemic conditions, such as cardiovascular, pulmonary, renal, hepatic, neurological, dermatological, endocrine, malignant, haematological, infectious, immune-deficient, psychiatric and other disorders, which could compromise the health of the volunteer during the study or interfere with the interpretation of the study results. These include, but are not limited to, any of the following:
- •- body weight <50 kg or Body Mass Index (BMI) <18.0 or >30.0 kg/m2 at screening;
- •- positive HIV, HBV or HCV screening tests;
- •- the use of immune modifying drugs within three months prior to study onset (inhaled and topical corticosteroids and oral anti-histamines exempted) or expected use of such during the study period;
- •- history of malignancy of any organ system (other than localized basal cell carcinoma of the skin), treated or untreated, within the past 5 years;
- •- any history of treatment for severe psychiatric disease by a psychiatrist in the past year;
- •- history of drug or alcohol abuse interfering with normal social function in the period of one year prior to study onset.
- •- Any clinically significant abnormalities (including extended QT interval) on electrocardiogram
- •2. The chronic use of any drug known to interact with praziquantel, or artesunate or lumefantrine metabolism (e.g. phenytoïn, carbamazepine, phenobarbital, primidon, dexamethason, rifampicine, cimetidine, flecaïnide, metoprolol, imipramine, amitriptyline, clomipramine, class IA and III anti-arrythmics, antipsychotics, antidepressants, macrolides, fluorchinolones, imidazole- and triazole antimycotics, antihistamines)
- •Because lumefantrine may cause extension of QT-time, chronic use of drugs with effect on QT interval are excluded from the study.
- •3. For female subjects: positive urine pregnancy test at screening.
- •4. Any history of schistosomiasis or treatment for schistosomiasis.
- •5. Positive serology for schistosomiasis or elevated serum or urine CAA at baseline.
- •6. Known hypersensitivity to or contra-indications (including co-medication) for use of praziquantel or, artesunate or lumefantrine.
- •7. Being an employee or student of the department of parasitology or infectious diseases of the LUMC.
研究者
相似试验
进行中（未招募）
不适用
A study to investigate the dose of Bilharzia worms that can be safely used to infect humans as a first step to enable testing Bilharzia vaccinesInfections and InfestationsSchistosomiasis [bilharziasis]SchistosomiasisISRCTN14033813ondon School of Hygiene & Tropical Medicine66
已完成
不适用
Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose FindingSchistosoma MansoniSchistosomiasisNCT02755324Leiden University17
已完成
不适用
Therapeutic Hookworm Phenotyping Studyautoimmune diseasesallergic diseasesInflammatory and Immune System - Autoimmune diseasesAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12619001129178Malaghan Institute of Medical Research18
已完成
不适用
Single-sex Female Controlled Human Schistosomiasis Mansoni InfectionSchistosomiasisSchistosomiasis MansoniNCT04269915Leiden University Medical Center13
招募中
不适用
Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical CenterNL-OMON42940eids Universitair Medisch Centrum4